Neurodegenerative disease: understanding the mechanisms of risk
Although sex differences in prevalence across a range of neurodegenerative conditions (e.g. Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis) are well known, there are associated differences in the profile of risks, clinical presentations, and responses to treatment in men and women that are largely overlooked. In this talk I will describe and discuss a number of ways in which improving our understanding of the interaction between sex, gender and disease processes might help with developing ‘personalised’ treatments to improve outcomes and quality of life for both those suffering from, and those caring for loved ones with ill health in later life.
About the Speaker
Clare Mackay, Professor of Imaging Neuroscience, Medical Sciences Division
Professor Clare Mackay is the co-ordinator of Oxford Dementia and Ageing Research (OxDARE) and Head of the Translational Neuroimaging Group. She is Associate Director of the Oxford Centre for Human Brain Activity (OHBA), which is part of the new Wellcome Centre for Integrative Neuroimaging. Clare leads the Older Adults & Dementia Theme for the NIHR Oxford Health Biomedical Research Centre, and the Imaging Informatics programme for the MRC Dementias Platform UK. I am also imaging lead for the Oxford Parkinson’s Disease Centre (OPDC), and the Whitehall II imaging study.
More Information at:
This event is part of a seminar series:
The Oxford Institute of Population Ageing and The George Institute for Global Health, at the Nuffield Department of Women’s and Reproductive Health are hosting a joint seminar series on Older Women’s Health, linked to two new initiatives at the University of Oxford – the Ageing Research Collaborative Hub @ Oxford and the Women’s Health @ Oxford Conveners: Professor S...
14 November 2019 17:00 - 18:30
Oxford Martin School
34 Broad Street (corner of Holywell and Catte Streets) Oxford OX1 3BD